 |
|
N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets
July 30, 2008In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction.
Their breakthrough research, featured as the cover story in a recent issue of Molecular Cell, describes the precise molecular and biochemical structure of drug targets known as neurotransmitter-sodium symporters (NSSs), and how cells use them to enable neural signaling in the brain. A second study, published in the latest issue of Nature Neuroscience, pinpoints where the drug molecules bind in the neurotransmitter transporter - their target in the human nervous system.
"These findings are so clear and detailed at the level of molecular behavior that they will be most valuable to developing more effective therapies for mood disorders and neurologic and psychiatric diseases, and to direct effective treatments for drug addiction to cocaine and amphetamines," says co-lead author Dr. Harel Weinstein, Chairman and Maxwell M. Upson Professor of Physiology and Biophysics, and director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al-saud Institute for Computational Biomedicine at Weill Cornell Medical College. "This research may also open the door to the development of new therapies for dopamine-neurotransmitter disorders such as Parkinson's disease, schizophrenia, and anxiety and depression."
To make their observations, the research team led by Dr. Jonathan Javitch, senior author of the Molecular Cell study and contributing author to the Nature Neuroscience study, and professor of Psychiatry and Pharmacology in the Center for Molecular Recognition at Columbia University Medical Center, stabilized different structural states of the neurotransmitter-sodium-symporter molecule that relate to steps in its function. This allowed the team to study how substrates and inhibitors affect the transition between these different states, and thus to understand the way in which its function is accomplished.
"Crystallography had allowed the identification of only one structural form of the molecule, but our experiments and computations were able to identify how this form changes and thereby add an understanding of the functional role of the different forms that the molecule must adopt to accomplish transport activity," says Dr. Javitch.
The main surprise was the realization that two binding sites on the transporter molecule need to be filled simultaneously and cooperate in order for transport to be driven across the cell membrane. For these studies, the scientists used the crystal structure of a bacterial transporter that is very similar to human neurotransmitter transporters. They performed computer simulations to reveal the path of the transported molecules into cells. Laboratory experimentation was used to test the computational predictions and validate the researchers' inferences.
Together, these procedures revealed a finely-tuned process in which two sodium ions bind and stabilize the transporter molecule for the correct positioning of the two messenger molecules - one deep in the center of the protein, and the other closer to the entrance. Like a key engaging a lock mechanism, this second binding causes changes in the transporter throughout the structure, allowing one of the two sodium molecules to move inward, and then release the deeply bound messenger and its sodium partner into the cell.
In the bacterial transporter studied, antidepressant molecules bind in the outer one of two sites, and stop the transport mechanism, leaving the messenger molecule outside the cell.
The second team of researchers, involving a collaboration of the Weinstein and Javitch labs with colleagues in Denmark (the labs of Ulrik Gether and Claus Loland), found that in the human dopamine transporter cocaine binds in the deep site, unlike the antidepressant binding in the bacterial transporter. Therefore, the researchers conclude that anti-cocaine therapy will be more complicated, because interfering with cocaine binding also means interference with the binding of natural messengers.
"This finding might steer anti-cocaine therapy in a completely new direction," says Dr. Weinstein.
Molecular understanding at this level of structural and dynamic detail is rare in the world of drug development, the authors note. Only about 15 percent of all drugs have a known molecular method-of-action, even though the effects of these drugs within the body - after very stringent and controlled laboratory testing - are well understood pharmacologically.
Contributing authors to the Molecular Cell study include Dr. Lei Shi from Weill Cornell Medical College, who had a major role in the computational simulations; Dr. Matthias Quick from Columbia University Medical Center and the New York State Psychiatric Institute, who had a major role in the experimental component; and Dr. Yongfang Zhao from Columbia University Medical Center.
Lead authors of the Nature Neuroscience study are first author Dr. Thijs Beuming of Weill Cornell Medical College and senior authors Drs. Claus Loland and Ulrik Gether of The Panum Institute of the University of Copenhagen, Denmark. Additional co-authors include Drs. Julie Kniazeff, Marianne Bergmann and Klaudia Raniszewska of The Panum Institute of the University of Copenhagen; Drs. Lei Shi and Luis Gracia of Weill Cornell; and Dr. Amy Hauck Newman of the National Institute on Drug Abuse (NIDA).
The NIH supported these studies, and it is noteworthy that both the Molecular Cell and the Nature Neuroscience study share an NIH funding source, a Program Project grant awarded by the National Institute on Drug Abuse and directed by Dr. Weinstein, with Drs. Javitch and Gether each directing one of the projects. Additional support came from the Danish Medical Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation and the Maersk Foundation - all in Europe.
Weill Cornell Medical College
To make their observations, the research team led by Dr. Jonathan Javitch, senior author of the Molecular Cell study and contributing author to the Nature Neuroscience study, and professor of Psychiatry and Pharmacology in the Center for Molecular Recognition at Columbia University Medical Center, stabilized different structural states of the neurotransmitter-sodium-symporter molecule that relate to steps in its function. This allowed the team to study how substrates and inhibitors affect the transition between these different states, and thus to understand the way in which its function is accomplished.
"Crystallography had allowed the identification of only one structural form of the molecule, but our experiments and computations were able to identify how this form changes and thereby add an understanding of the functional role of the different forms that the molecule must adopt to accomplish transport activity," says Dr. Javitch.
The main surprise was the realization that two binding sites on the transporter molecule need to be filled simultaneously and cooperate in order for transport to be driven across the cell membrane. For these studies, the scientists used the crystal structure of a bacterial transporter that is very similar to human neurotransmitter transporters. They performed computer simulations to reveal the path of the transported molecules into cells. Laboratory experimentation was used to test the computational predictions and validate the researchers' inferences.
Together, these procedures revealed a finely-tuned process in which two sodium ions bind and stabilize the transporter molecule for the correct positioning of the two messenger molecules - one deep in the center of the protein, and the other closer to the entrance. Like a key engaging a lock mechanism, this second binding causes changes in the transporter throughout the structure, allowing one of the two sodium molecules to move inward, and then release the deeply bound messenger and its sodium partner into the cell.
In the bacterial transporter studied, antidepressant molecules bind in the outer one of two sites, and stop the transport mechanism, leaving the messenger molecule outside the cell.
The second team of researchers, involving a collaboration of the Weinstein and Javitch labs with colleagues in Denmark (the labs of Ulrik Gether and Claus Loland), found that in the human dopamine transporter cocaine binds in the deep site, unlike the antidepressant binding in the bacterial transporter. Therefore, the researchers conclude that anti-cocaine therapy will be more complicated, because interfering with cocaine binding also means interference with the binding of natural messengers.
"This finding might steer anti-cocaine therapy in a completely new direction," says Dr. Weinstein.
Molecular understanding at this level of structural and dynamic detail is rare in the world of drug development, the authors note. Only about 15 percent of all drugs have a known molecular method-of-action, even though the effects of these drugs within the body - after very stringent and controlled laboratory testing - are well understood pharmacologically.
Contributing authors to the Molecular Cell study include Dr. Lei Shi from Weill Cornell Medical College, who had a major role in the computational simulations; Dr. Matthias Quick from Columbia University Medical Center and the New York State Psychiatric Institute, who had a major role in the experimental component; and Dr. Yongfang Zhao from Columbia University Medical Center.
Lead authors of the Nature Neuroscience study are first author Dr. Thijs Beuming of Weill Cornell Medical College and senior authors Drs. Claus Loland and Ulrik Gether of The Panum Institute of the University of Copenhagen, Denmark. Additional co-authors include Drs. Julie Kniazeff, Marianne Bergmann and Klaudia Raniszewska of The Panum Institute of the University of Copenhagen; Drs. Lei Shi and Luis Gracia of Weill Cornell; and Dr. Amy Hauck Newman of the National Institute on Drug Abuse (NIDA).
The NIH supported these studies, and it is noteworthy that both the Molecular Cell and the Nature Neuroscience study share an NIH funding source, a Program Project grant awarded by the National Institute on Drug Abuse and directed by Dr. Weinstein, with Drs. Javitch and Gether each directing one of the projects. Additional support came from the Danish Medical Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation and the Maersk Foundation - all in Europe.
Weill Cornell Medical College
Cocaine Current Events and Cocaine News RSSStress-induced changes in brain circuitry linked to cocaine relapse
Stress-evoked changes in circuits that regulate serotonin in certain parts of the brain can precipitate a low mood and a relapse in cocaine-seeking, based on mouse studies published online this week in the Proceedings of the National Academy of Sciences.
Cocaine exposure during pregnancy leads to impulsivity in male, not female, monkeys
Adult male monkeys exposed to cocaine while in the womb have poor impulse control and may be more vulnerable to drug abuse than female monkeys, even a decade or more after the exposure, according to a new study by researchers at Wake Forest University School of Medicine. The findings could lead to a better understanding of human drug abuse.
Think what you eat: Studies point to cellular factors linking diet and behavior
New research released today is affirming a long-held maxim: you are what you eat - and, more to the point, what you eat has a profound influence on the brain.
Global public health the focus of scientific conference
Counterfeit and adulterated food and drugs and advances in measurement science used to detect them emerged as key themes of the Annual Scientific Meeting (ASM) hosted by the U.S. Pharmacopeial (USP) Convention.
Computer Model Shows Changes in Brain Mechanisms for Cocaine Addicts
About 2 million Americans currently use cocaine for its temporary side-effects of euphoria, which have contributed to making it one of the most dangerous and addictive drugs in the country.
Researchers explore long-term adolescent vulnerability to drugs
As part of efforts to understand drug abuse, Georgia State University researchers are finding that adolescent rats appear to be less vulnerable to the long-term effects of withdrawal and relapse in certain types of drug use than rats that take the drugs in adulthood.
Deaths from Unintentional Injuries Increase for Many Groups
While the total mortality rate from unintentional injury increased in the U.S. by 11 percent between 1999 and 2005, far larger increases were seen in some subgroups analyzed by age, race, ethnicity and type of injury by researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy.
New study: Up to 90 percent of US paper money contains traces of cocaine
You probably have cocaine in your wallet, purse, or pocket. Sound unlikely or outrageous? Think again! In what researchers describe as the largest, most comprehensive analysis to date of cocaine contamination in banknotes, scientists are reporting that cocaine is present in up to 90 percent of paper money in the United States, particularly in large cities such as Baltimore, Boston, and Detroit.
Wastewater used to map illicit drug use
A team of researchers has mapped patterns of illicit drug use across the state of Oregon using a method of sampling municipal wastewater before it is treated.
New gene discovery links obesity to the brain
A variation in a gene that is active in the central nervous system is associated with increased risk for obesity.
More Cocaine Current Events and Cocaine News Articles
 |
Cocaine: An Unauthorized Biography by Dominic Streatfeild (Author) The story of cocaine isn't just about crime and profit; it's about psychoanalysis, about empire building, about exploitation, emancipation, and, ultimately, about power. To tell the story of the twentieth century without reference to this drug and its contribution is to miss a vital and fascinating strand of social history. Streatfeild examines the story of cocaine from its first medical uses to the world-wide chaos it causes today. His research takes him from the arcane reaches of the British Library to the isolation cells of America's most secure prisons; from the crackhouses of New York to the jungles of Bolivia and Colombia. |
 |
The Cocaine Chronicles by Jervey Tervalon (Editor), Gary Phillips (Editor) NOTHING TO SNORT AT, this ambitious anthology of jaw-grinding criminal behavior is masterfully curated by acclaimed authors Phillips and Tervalon. Cocaine, that most troubling and fascinating of substances is the subject, the subtext, the whys and whereofs in COCAINE CHRONICLES, a collection of original short stories that are funny and harrowing, sad and scary, but at all times riveting. COCAINE CHRONICLES contains tough tales by a cross-section of today's most thought-provoking writers. |
 |
Doctor Dealer: The Rise and Fall of an All-American Boy and His Multimillion-Dollar Cocaine Empire by Mark Bowden (Author) Doctor Dealer is the story of Larry Lavin, a bright, charismatic young man who rose from his working-class upbringing to win a scholarship to a prestigious boarding school, earn Ivy League college and dental degrees, and buy his family a house in one of Philadelphia's most exclusive suburbs. But behind the facade of his success was a dark secret -- at every step of the way he was building the foundation for a cocaine empire that would grow to generate over $60 million in annual sales. Award-winning journalist Mark Bowden tells the saga of Lavin's rise and fall with the gripping, novelistic narrative style that won him international acclaim as the author of the New York Times best-seller Black Hawk Down. "Immensely readable . . . eye-popping . . . a smoothly crafted, exciting,... |
 |
The Cocaine Kids: The Inside Story Of A Teenage Drug Ring by Terry Tempest Williams (Author) Sociologist Terry Williams brings us a story straight out of today's headlines--teens becoming big-time drug dealers--and asks us to take another look at who is winning the war on drugs. "A breath-takting ethnographic account of young drug deadlers."--Boston Herald. |
 |
The Pleasures of Cocaine by Adam Gottlieb (Author) The Pleasures of Cocaine conveys the impartial facts of the uses and abuses of cocaine. Without bias, many different aspects are covered: History, effects, uses, pleasures, dangers Avoiding abusive side effects Determining quality Substances used to cut coke and thier effects Testing for purity and removing impurities Improving appearance Inside look at dealing Cultivation of coca plants Coca leaf botany |
 |
Cocaine by Z-Ro |
 |
Andean Cocaine: The Making of a Global Drug by Paul Gootenberg (Author) Illuminating a hidden and fascinating chapter in the history of globalization, Paul Gootenberg chronicles the rise of one of the most spectacular and now illegal Latin American exports: cocaine. Gootenberg traces cocaine's history from its origins as a medical commodity in the nineteenth century to its repression during the early twentieth century and its dramatic reemergence as an illicit good after World War II. Connecting the story of the drug's transformations is a host of people, products, and processes: Sigmund Freud, Coca-Cola, and Pablo Escobar all make appearances, exemplifying the global influences that have shaped the history of cocaine. But Gootenberg decenters the familiar story to uncover the roles played by hitherto obscure but vital Andean actors as well--for example,... |
 |
White Lines: Writers on Cocaine by Geno Zanetti (Editor), Stephen Hyde (Editor) Blow, candy, Charlie, coke, go, ice, rock, snow, crack. Whatever you call it, thrill seekers have surrendered to cocaine’s siren call, paid their toll, and sold their souls. Its embrace can be deadly, a place of no return, the ultimate rush, public enemy number one. From the gutter to the penthouse, inner city to outer burb, from the Third World coca farmer to the executive addict, coke is the lifeblood of a global black economy and an outlaw underground. Coke has also been dark muse, torment, and theme to many of our greatest writers. White Lines gathers these literary thrill seekers in a classic and contemporary snort through the fog- and fear-filled streets of Victorian London to the dance macabre of the post-Vietnam culture of the 1970s, from the couch of Dr. Freud and the bacchanal... |
 |
Cocaine Eric Clapton (Primary Contributor) |
 |
Cocaine Addiction: Treatment, Recovery, and Relapse Prevention by Arnold Washton (Author) A detailed guide to clinical assessment and treatment of cocaine addiction, this is a concise book that emphasizes on outpatient treatment and relapse prevention strategies. |
| © 2009 BrightSurf.com |